Clinical trial aims to treat canine pancreatitis
ISK seeks participants for a study to identify ACP treatments targeting an affected dog’s LFA-1 pathway February 6, 2020 The first treatment option for acute canine pancreatitis (ACP) may soon be a reality. Ishihara Sangyo Kaisha and its US subsidiary, ISK Animal Health (known collectively as “ISK”), along with trial partner, AlcheraBio, are seeking clinics…